Shares of Pfizer Inc. (NYSE:PFE) continue to head higher on Wednesday, a day after the company announced that it has secured a three-year grace period from President Donald Trump's tariffs on pharmaceuticals. This will enable Pfizer to offer its medication at significantly discounted prices compared to current rates.This news appears to have triggered a breakout in the shares. This can have bullish implications and may indicate that they will continue to move higher. This is why Pfizer is our Stock of the D ...

Fair enough. Mike, hang tight with us for a second. We are going to turn to Beimo's Evan Seagerman for his reaction to President Trump's new tariffs on the pharma sector.Some pretty big numbers, but then Aan Jabvers is telling us bilateral trade agreements will be honored. So maybe not as bad as feared, and it it doesn't seem like uh the stocks themselves are really worried here either. Evan, explain to us why.>> Exactly. So it's a 100% tariff, but it doesn't apply if a pharmaceutical manufacturer is buildi ...